In a report released today, Edward White from H.C. Wainwright reiterated a Hold rating on Adicet Bio (ACET – Research Report). The ...
Adicet Bio ( (ACET) ) has provided an update. Adicet Bio has received FDA clearance to expand its investigational new drug ...
After hours: October 3 at 6:41 PM EDT ...
加利福尼亚州红木城和马萨诸塞州波士顿 - 临床阶段生物技术公司Adicet Bio, Inc. (NASDAQ: ...
周四,H.C. Wainwright维持对Adicet Bio Inc. (NASDAQ: ACET)股票的中性立场,此前该公司宣布美国食品和药物管理局(FDA)同意修改其新药研究申请(IND)。这项修改将允许Adicet Bio在其正在进行的1期试验中评估其药物候选ADI-001对其他自身免疫性疾病的治疗效果。 Adicet Bio的同种异体γδ T细胞产品候选ADI-001包含一个抗CD20 ...
In a report released today, Asthika Goonewardene from Truist Financial assigned a Buy rating to Adicet Bio (ACET – Research Report). The company’s shares closed yesterday at $1.52 ...